Research graph
References from From Reflection to Implementation: Tailored Clinical Development of a Pembrolizumab Biosimilar Candidate. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1182/blood-2014-06-583617
10.1182/blood-2014-06-583617 · 2014 · External reference
Unresolved reference
External reference
10.1016/j.drudis.2020.09.006
10.1016/j.drudis.2020.09.006 · 2020 · External reference
10.1007/s40259-023-00631-4
10.1007/s40259-023-00631-4 · 2023 · External reference
10.1002/cpdd.1349
10.1002/cpdd.1349 · 2023 · External reference
10.1007/s40259-020-00422-1
10.1007/s40259-020-00422-1 · 2020 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1007/s40265-025-02168-y
10.1007/s40265-025-02168-y · 2025 · External reference
10.3390/ijms241310684
10.3390/ijms241310684 · 2023 · External reference
10.1038/cr.2016.77
10.1038/cr.2016.77 · 2017 · External reference
10.1007/s40268-024-00485-3
10.1007/s40268-024-00485-3 · 2024 · External reference
10.1016/j.ejps.2022.106171
10.1016/j.ejps.2022.106171 · 2022 · External reference
10.1002/psp4.12139
10.1002/psp4.12139 · 2017 · External reference
10.1002/psp4.12132
10.1002/psp4.12132 · 2017 · External reference
10.1186/s40425-017-0242-5
10.1186/s40425-017-0242-5 · 2017 · External reference
10.1016/j.ejca.2024.113530
10.1016/j.ejca.2024.113530 · 2024 · External reference
Unresolved reference
External reference
10.1002/jcph.6165
10.1002/jcph.6165 · 2025 · External reference
10.1007/s40259-025-00733-1
10.1007/s40259-025-00733-1 · 2025 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1002/cpt.2785
10.1002/cpt.2785 · 2023 · External reference
10.1038/s41598-021-85329-9
10.1038/s41598-021-85329-9 · 2021 · External reference
10.1002/cpdd.1349
10.1002/cpdd.1349 · ExternalCitation · doi-reference
10.1002/cpt.2785
10.1002/cpt.2785 · ExternalCitation · doi-reference
10.1002/jcph.6165
10.1002/jcph.6165 · ExternalCitation · doi-reference
10.1002/psp4.12132
10.1002/psp4.12132 · ExternalCitation · doi-reference
10.1002/psp4.12139
10.1002/psp4.12139 · ExternalCitation · doi-reference
10.1007/s40259-020-00422-1
10.1007/s40259-020-00422-1 · ExternalCitation · doi-reference
10.1007/s40259-023-00631-4
10.1007/s40259-023-00631-4 · ExternalCitation · doi-reference
10.1007/s40259-025-00733-1
10.1007/s40259-025-00733-1 · ExternalCitation · doi-reference
10.1007/s40265-025-02168-y
10.1007/s40265-025-02168-y · ExternalCitation · doi-reference
10.1007/s40268-024-00485-3
10.1007/s40268-024-00485-3 · ExternalCitation · doi-reference
10.1016/j.drudis.2020.09.006
10.1016/j.drudis.2020.09.006 · ExternalCitation · doi-reference
10.1016/j.ejca.2024.113530
10.1016/j.ejca.2024.113530 · ExternalCitation · doi-reference
10.1016/j.ejps.2022.106171
10.1016/j.ejps.2022.106171 · ExternalCitation · doi-reference
10.1038/cr.2016.77
10.1038/cr.2016.77 · ExternalCitation · doi-reference
10.1038/s41598-021-85329-9
10.1038/s41598-021-85329-9 · ExternalCitation · doi-reference
10.1182/blood-2014-06-583617
10.1182/blood-2014-06-583617 · ExternalCitation · doi-reference
10.1186/s40425-017-0242-5
10.1186/s40425-017-0242-5 · ExternalCitation · doi-reference
10.3390/ijms241310684
10.3390/ijms241310684 · ExternalCitation · doi-reference
